Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XEN-D0501 Add-on to Metformin in Type 2 Diabetes
NCT05353686Phase 2Completed
- Sponsor
- Pila Pharma
- Start
- Feb 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of XEN-D0501 in type 2 diabetes mellitus (T2DM), sponsored by Pila Pharma. Started Feb 2019; status: completed.
02
Drugs
XEN-D0501
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05353686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05353686.